Browse by UCL people
Group by: Type | Date
Number of items: 67.
Article
Ahmed, RM;
Paterson, RW;
Warren, JD;
Zetterberg, H;
O'Brien, JT;
Fox, NC;
Halliday, GM;
(2014)
Biomarkers in dementia: clinical utility and new directions.
J Neurol Neurosurg Psychiatry
, 85
(12)
1426 - 1434.
10.1136/jnnp-2014-307662.
|
Alawode, DOT;
Heslegrave, AJ;
Ashton, NJ;
Karikari, TK;
Simrén, J;
Montoliu-Gaya, L;
Pannee, J;
... Zetterberg, H; + view all
(2021)
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.
Journal of Internal Medicine
, 290
(3)
pp. 583-601.
10.1111/joim.13332.
|
Arber, C;
Alatza, A;
Leckey, CA;
Paterson, RW;
Zetterberg, H;
Wray, S;
(2021)
Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.
Journal of Neurochemistry
10.1111/jnc.15315.
(In press).
|
Arber, C;
Toombs, J;
Lovejoy, C;
Ryan, NS;
Paterson, RW;
Willumsen, N;
Gkanatsiou, E;
... Wray, S; + view all
(2020)
Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.
Molecular Psychiatry
, 25
pp. 2919-2931.
10.1038/s41380-019-0410-8.
|
Balendra, Rubika;
North, Matthew;
Kumar, Guru;
Qutab, Saad;
Raouf, Hamid Aminy;
Delamont, Shane S;
Chong, MS;
... Swayne, Orlando BC; + view all
(2022)
Raised Intracranial Pressure (Pseudotumour Cerebri) Associated With Severe Acute Respiratory Syndrome Coronavirus 2.
Journal of Neuro-Ophthalmology
, 42
(2)
e459-e462.
10.1097/WNO.0000000000001469.
|
Banerjee, G;
Ambler, G;
Keshavan, A;
Paterson, RW;
Foiani, MS;
Toombs, J;
Heslegrave, A;
... Werring, DJ; + view all
(2020)
Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy.
Journal of Alzheimer's Disease
, 74
(4)
pp. 1189-1201.
10.3233/JAD-191254.
(In press).
|
Banerjee, G;
Forsgard, N;
Ambler, G;
Keshavan, A;
Paterson, RW;
Foiani, MS;
Toombs, J;
... Werring, DJ; + view all
(2021)
Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
Journal of Neurology
10.1007/s00415-021-10711-6.
(In press).
|
Benjamin, LA;
Paterson, RW;
Moll, R;
Pericleous, C;
Brown, R;
Mehta, PR;
Athauda, D;
... Efthymiou, M; + view all
(2021)
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
EClinicalMedicine
, Article 101070. 10.1016/j.eclinm.2021.101070.
(In press).
|
Biesbroek, J Matthijs;
Coenen, Mirthe;
DeCarli, Charles;
Fletcher, Evan M;
Maillard, Pauline M;
Alzheimer's Disease Neuroimaging Initiative;
Barkhof, Frederik;
... Biessels, Geert Jan; + view all
(2024)
Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
10.1002/alz.13765.
(In press).
|
|
Bridel, C;
van Wieringen, WN;
Zetterberg, H;
Tijms, BM;
Teunissen, CE;
and the NFL Group;
Alvarez-Cermeño, JC;
... Wild, EJ; + view all
(2019)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
JAMA Neurology
10.1001/jamaneurol.2019.1534.
(In press).
|
Canas, LS;
Sudre, CH;
De Vita, E;
Nihat, A;
Mok, TH;
Slattery, CF;
Paterson, RW;
... Modat, M; + view all
(2019)
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.
NeuroImage: Clinical
, Article 102051. 10.1016/j.nicl.2019.102051.
(In press).
|
Clark, CN;
Golden, HL;
McCallion, O;
Nicholas, JM;
Cohen, MH;
Slattery, CF;
Paterson, RW;
... Warren, JD; + view all
(2018)
Music models aberrant rule decoding and reward valuation in dementia.
Social Cognitive and Affective Neuroscience
, 13
(2)
pp. 192-202.
10.1093/scan/nsx140.
|
Coenen, Mirthe;
Biessels, Geert Jan;
DeCarli, Charles;
Fletcher, Evan F;
Maillard, Pauline M;
Alzheimer's Disease Neuroimaging Initiative;
Barkhof, Frederik;
... Kuijf, Hugo J; + view all
(2023)
Spatial distributions of white matter hyperintensities on brain MRI: A pooled analysis of individual participant data from 11 memory clinic cohorts.
NeuroImage: Clinical
, 40
, Article 103547. 10.1016/j.nicl.2023.103547.
|
Coenen, Mirthe;
Kuijf, Hugo J;
Huenges Wajer, Irene MC;
Duering, Marco;
Wolters, Frank J;
Fletcher, Evan F;
Maillard, Pauline M;
... Biesbroek, J Matthijs; + view all
(2022)
Strategic white matter hyperintensity locations for cognitive impairment: A multicenter lesion-symptom mapping study in 3525 memory clinic patients.
Alzheimer's & Dementia
10.1002/alz.12827.
(In press).
|
den Haan, J;
Csinscik, L;
Parker, T;
Paterson, RW;
Slattery, CF;
Foulkes, A;
Bouwman, FH;
... Yong, KXX; + view all
(2019)
Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.
Alzheimer's Research and Therapy
, 11
, Article 62. 10.1186/s13195-019-0516-x.
|
Drews, A;
De, S;
Flagmeier, P;
Wirthensohn, DC;
Chen, W-H;
Whiten, DR;
Vincke, C;
... Klenerman, D; + view all
(2017)
Inhibiting the Ca2+ Influx Induced by Human CSF.
Cell Reports
, 21
(11)
pp. 3310-3316.
10.1016/j.celrep.2017.11.057.
|
Ehrenberg, AJ;
Khatun, A;
Coomans, E;
Betts, MJ;
Capraro, F;
Thijssen, EH;
Senkevich, K;
... Paterson, RW; + view all
(2020)
Relevance of biomarkers across different neurodegenerative.
Alzheimer's Research & Therapy
, 12
, Article 56. 10.1186/s13195-020-00601-w.
|
Firth, NC;
Primativo, S;
Marinescu, R-V;
Shakespeare, TJ;
Suarez-Gonzalez, A;
Lehmann, M;
Carton, A;
... Crutch, SJ; + view all
(2019)
Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy.
Brain
, 142
(7)
pp. 2082-2095.
10.1093/brain/awz136.
|
Fletcher, PD;
Downey, LE;
Golden, HL;
Clark, CN;
Slattery, CF;
Paterson, RW;
Rohrer, JD;
... Warren, JD; + view all
(2015)
Pain and temperature processing in dementia: a clinical and neuroanatomical analysis.
Brain
, 138
(11)
pp. 3360-3372.
10.1093/brain/awv276.
|
Fletcher, PD;
Downey, LE;
Golden, HL;
Clark, CN;
Slattery, CF;
Paterson, RW;
Schott, JM;
... Warren, JD; + view all
(2015)
Auditory hedonic phenotypes in dementia: A behavioural and neuroanatomical analysis.
Cortex
, 67
pp. 95-105.
10.1016/j.cortex.2015.03.021.
|
Foiani, MS;
Cicognola, C;
Ermann, N;
Woollacott, IOC;
Heller, C;
Heslegrave, AJ;
Keshavan, A;
... Rohrer, JD; + view all
(2019)
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-319266.
(In press).
|
Golden, HL;
Clark, CN;
Nicholas, JM;
Cohen, MH;
Slattery, CF;
Paterson, RW;
Foulkes, AJ;
... Warren, JD; + view all
(2016)
Music Perception in Dementia.
Journal of Alzheimer's Disease
, 55
(3)
pp. 933-949.
10.3233/JAD-160359.
|
Hansson, K;
Dahlen, R;
Hansson, O;
Pernevik, E;
Paterson, R;
Schott, JM;
Magdalinou, N;
... Gobom, J; + view all
(2019)
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease.
Clinical Mass Spectrometry
, 14
(Part B)
pp. 74-82.
10.1016/j.clinms.2019.07.002.
|
Heslegrave, A;
Heywood, W;
Paterson, R;
Magdalinou, N;
Svensson, J;
Johansson, P;
Ohrfelt, A;
... Zetterberg, H; + view all
(2016)
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
Molecular Neurodegeneration
, 11
, Article 3. 10.1186/s13024-016-0071-x.
|
Heywood, WE;
Galimberti, D;
Bliss, E;
Sirka, E;
Paterson, RW;
Magdalinou, NK;
Carecchio, M;
... Mills, K; + view all
(2015)
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.
Molecular Neurodegeneration
, 10
, Article 64. 10.1186/s13024-015-0059-y.
|
Heywood, WE;
Galimberti, D;
Bliss, E;
Sirka, E;
Paterson, RW;
Magdalinou, NK;
Carecchio, M;
... Mills, K; + view all
(2016)
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay (vol 10, 64, 2015).
[Corrigendum].
Molecular Neurodegeneration
, 11
, Article 20. 10.1186/s13024-016-0086-3.
|
Horie, Kanta;
Barthélemy, Nicolas R;
Spina, Salvatore;
VandeVrede, Lawren;
He, Yingxin;
Paterson, Ross W;
Wright, Brenton A;
... Sato, Chihiro; + view all
(2022)
CSF tau microtubule-binding region identifies pathological changes in primary tauopathies.
Nature Medicine
10.1038/s41591-022-02075-9.
(In press).
|
Keddie, S;
Pakpoor, J;
Mousele, C;
Pipis, M;
Machado, PM;
Foster, M;
Record, CJ;
... Lunn, MP; + view all
(2021)
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Brain
, 144
(2)
pp. 682-693.
10.1093/brain/awaa433.
|
Keshavan, Ashvini;
O'Shea, Frankie;
Chapman, Miles D;
Hart, Melanie S;
Lunn, Michael Pt;
Paterson, Ross W;
Rohrer, Jonathan D;
... Schott, Jonathan M; + view all
(2022)
CSF biomarkers for dementia.
Practical Neurology
10.1136/practneurol-2021-003310.
(In press).
|
Khatun, A;
Paterson, RW;
Schöll, M;
(2020)
University College London/University of Gothenburg PhD course "Biomarkers in neurodegenerative diseases" 2019—course organisation.
Alzheimer's Research & Therapy
, 12
, Article 18. 10.1186/s13195-020-0583-z.
|
Liu, KY;
Howard, R;
Banerjee, S;
Comas‐Herrera, A;
Goddard, J;
Knapp, M;
Livingston, G;
... Burns, A; + view all
(2021)
Dementia wellbeing and COVID‐19: Review and expert consensus on current research and knowledge gaps.
International Journal of Geriatric Psychiatry
, 36
(11)
pp. 1597-1639.
10.1002/gps.5567.
|
Mok, Tze How;
Nihat, Akin;
Majbour, Nour;
Sequeira, Danielle;
Holm-Mercer, Leah;
Coysh, Thomas;
Darwent, Lee;
... Mead, Simon; + view all
(2023)
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Brain
, Article awad101. 10.1093/brain/awad101.
|
Norsworthy, PJ;
Thompson, AGB;
Mok, TH;
Guntoro, F;
Dabin, LC;
Nihat, A;
Paterson, RW;
... Viré, EA; + view all
(2020)
A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis.
Nature Communications
, 11
(1)
, Article 3960. 10.1038/s41467-020-17655-x.
|
Obrocki, P;
Khatun, A;
Ness, D;
Senkevich, K;
Hanrieder, J;
Capraro, F;
Mattsson, N;
... Zetterberg, H; + view all
(2020)
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
Alzheimer's Research & Therapy
, 12
(1)
, Article 20. 10.1186/s13195-020-00586-6.
|
Parker, TD;
Slattery, CF;
Yong, KXX;
Nicholas, JM;
Paterson, RW;
Foulkes, AJM;
Malone, IB;
... Schott, JM; + view all
(2019)
Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease.
NeuroImage: Clinical
, Article 101632. 10.1016/j.nicl.2018.101632.
(In press).
|
Parker, TD;
Slattery, CF;
Zhang, J;
Nicholas, JM;
Paterson, RW;
Foulkes, AJM;
Malone, IB;
... Schott, JM; + view all
(2018)
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging.
Human Brain Mapping
, 39
(7)
pp. 3005-3017.
10.1002/hbm.24056.
|
Paterson, RW;
Abdi, Z;
Haines, A;
Schott, JM;
(2016)
Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy.
Clinical Neurology and Neurosurgery
, 144
pp. 64-66.
10.1016/j.clineuro.2016.02.036.
|
Paterson, RW;
Bartlett, JW;
Blennow, K;
Fox, NC;
Shaw, LM;
Trojanowski, JQ;
Zetterberg, H;
(2014)
Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.
Transl Psychiatry
, 4
, Article e419. 10.1038/tp.2014.58.
|
Paterson, RW;
Benjamin, LA;
Mehta, PR;
Brown, RL;
Athauda, D;
Ashton, NJ;
Leckey, CA;
... Schott, JM; + view all
(2021)
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Brain Communications
, 3
(3)
, Article fcab099. 10.1093/braincomms/fcab099.
|
Paterson, RW;
Brown, RL;
Benjamin, L;
Nortley, R;
Wiethoff, S;
Bharucha, T;
Jayaseelan, DL;
... UCL Queen Square National Hospital for Neurology and Neurosurger; + view all
(2020)
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.
Brain
10.1093/brain/awaa240.
(In press).
|
Paterson, RW;
Gabelle, A;
Lucey, BP;
Barthélemy, NR;
Leckey, CA;
Hirtz, C;
Lehmann, S;
... Bateman, RJ; + view all
(2019)
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases.
Nature Reviews Neurology
, 15
pp. 419-427.
10.1038/s41582-019-0222-0.
|
Paterson, RW;
Heywood, WE;
Heslegrave, AJ;
Magdalinou, NK;
Andreasson, U;
Sirka, E;
Bliss, E;
... Schott, JM; + view all
(2016)
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.
Translational Psychiatry
, 6
, Article e952. 10.1038/tp.2016.194.
|
Paterson, RW;
Schott, JM;
Zandi, MS;
Armstrong, R;
Vincent, A;
(2014)
Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: Experience from a tertiary referral centre.
Journal of Neurology, Neurosurgery and Psychiatry
, 85
(6)
625 - 630.
10.1136/jnnp-2013-305218.
|
Paterson, RW;
Slattery, CF;
Poole, T;
Nicholas, JM;
Magdalinou, NK;
Toombs, J;
Chapman, MD;
... Schott, JM; + view all
(2018)
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Alzheimer's Research & Therapy
, 10
, Article 32. 10.1186/s13195-018-0361-3.
|
Paterson, RW;
Toombs, J;
Chapman, MD;
Nicholas, JM;
Heslegrave, AJ;
Slattery, CF;
Foulkes, AJM;
... Schott, JM; + view all
(2015)
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 1
(3)
pp. 380-384.
10.1016/j.dadm.2015.06.003.
|
Pavisic, IM;
Firth, NF;
Parsons, S;
Martinez Rego, D;
Shakespeare, TJ;
Yong, KXX;
Slattery, CF;
... Primativo, S; + view all
(2017)
Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions.
Frontiers in Neurology
, 8
, Article 377. 10.3389/fneur.2017.00377.
|
Pemberton, HG;
Goodkin, O;
Prados, F;
Das, RK;
Vos, SB;
Moggridge, J;
Coath, W;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study.
European Radiology
10.1007/s00330-020-07455-8.
(In press).
|
Sani, TP;
Bond, RL;
Marshall, CR;
Hardy, CJD;
Russell, LL;
Moore, KM;
Slattery, CF;
... Warren, JD; + view all
(2019)
Sleep symptoms in syndromes of frontotemporal dementia and Alzheimer's disease: A proof-of-principle behavioural study.
eNeurologicalSci
, 17
, Article 100212. 10.1016/j.ensci.2019.100212.
|
Shakespeare, TJ;
Kaski, D;
Yong, KX;
Paterson, RW;
Slattery, CF;
Ryan, NS;
Schott, JM;
(2015)
Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy.
Brain
, 138
pp. 1976-1991.
10.1093/brain/awv103.
|
Singh, Bhagteshwar;
Lant, Suzannah;
Cividini, Sofia;
Cattrall, Jonathan WS;
Goodwin, Lynsey C;
Benjamin, Laura;
Michael, Benedict D;
... Solomon, Tom; + view all
(2022)
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis.
PLoS One
, 17
(6)
, Article e0263595. 10.1371/journal.pone.0263595.
|
Slattery, CF;
Agustus, JL;
Paterson, RW;
McCallion, O;
Foulkes, AJM;
Macpherson, K;
Carton, AM;
... Warren, JD; + view all
(2019)
The functional neuroanatomy of musical memory in Alzheimer's disease.
Cortex
10.1016/j.cortex.2019.02.003.
(In press).
|
Slattery, CF;
Zhang, J;
Paterson, RW;
Foulkes, AJM;
Carton, A;
Macpherson, K;
Mancini, L;
... Schott, JM; + view all
(2017)
ApoE influences regional white-matter axonal density loss in Alzheimer's disease.
Neurobiology of Aging
, 57
pp. 8-17.
10.1016/j.neurobiolaging.2017.04.021.
|
Suárez-González, A;
Lehmann, M;
Shakespeare, TJ;
Yong, KXX;
Paterson, RW;
Slattery, CF;
Foulkes, AJM;
... Crutch, SJ; + view all
(2016)
Effect of age at onset on cortical thickness and cognition in posterior cortical atrophy.
Neurobiology of Aging
, 44
pp. 108-113.
10.1016/j.neurobiolaging.2016.04.012.
|
Toombs, J;
Paterson, RW;
Schott, JM;
Zetterberg, H;
(2014)
Amyloid-beta 42 adsorption following serial tube transfer.
ALZHEIMERS RESEARCH & THERAPY
, 6
(1)
10.1186/alzrt236.
|
Toombs, J;
Foiani, MS;
Paterson, RW;
Heslegrave, A;
Wray, S;
Schott, JM;
Fox, NC;
... Zetterberg, H; + view all
(2017)
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-beta Concentration.
Journal of Alzheimer's Disease
, 56
(3)
pp. 885-891.
10.3233/JAD-161126.
|
Toombs, J;
Foiani, MS;
Wellington, H;
Paterson, RW;
Arber, C;
Heslegrave, A;
Lunn, MP;
... Zetterberg, H; + view all
(2018)
Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 10
pp. 311-321.
10.1016/j.dadm.2018.02.005.
|
Veale, T;
Malone, IB;
Poole, T;
Parker, TD;
Slattery, CF;
Paterson, RW;
Foulkes, AJM;
... Cash, DM; + view all
(2021)
Loss and dispersion of superficial white matter in Alzheimer's disease: a diffusion MRI study.
Brain Communications
, 3
(4)
, Article fcab272. 10.1093/braincomms/fcab272.
|
Wellington, H;
Paterson, RW;
Suarez-Gonzalez, A;
Poole, T;
Frost, C;
Sjobom, U;
Slattery, CF;
... Schott, JM; + view all
(2018)
CSF Neurogranin or Tau distinguish typical and atypical Alzheimer Disease.
Annals of Clinical and Translational Neurology
, 5
(2)
pp. 162-171.
10.1002/acn3.518.
|
Weston, PS;
Paterson, RW;
Dickson, J;
Barnes, A;
Bomanji, JB;
Kayani, I;
Lunn, MP;
... Schott, JM; + view all
(2016)
Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?
Journal of Alzheimer's Disease
, 54
(4)
pp. 1297-1302.
10.3233/JAD-160302.
|
Weston, PS;
Paterson, RW;
Modat, M;
Burgos, N;
Cardoso, MJ;
Magdalinou, N;
Lehmann, M;
... Schott, JM; + view all
(2015)
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 1
(4)
pp. 440-446.
10.1016/j.dadm.2015.10.001.
|
Woollacott, IOC;
Nicholas, JM;
Heller, C;
Foiani, MS;
Moore, KM;
Russell, LL;
Paterson, RW;
... Rohrer, JD; + view all
(2020)
Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Dementia and Geriatric Cognitive Disorders
, 49
(1)
pp. 56-76.
10.1159/000506282.
|
Woollacott, IOC;
Nicholas, JM;
Heslegrave, A;
Heller, C;
Foiani, MS;
Dick, KM;
Russell, LL;
... Rohrer, JD; + view all
(2018)
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Alzheimer's Research & Therapy
, 10
, Article 79. 10.1186/s13195-018-0405-8.
|
Yong, KXX;
McCarthy, ID;
Poole, T;
Suzuki, T;
Yang, B;
Carton, AM;
Holloway, C;
... Crutch, SJ; + view all
(2018)
Navigational cue effects in Alzheimer's disease and posterior cortical atrophy.
Annals of Clinical and Translational Neurology
, 5
(6)
pp. 697-709.
10.1002/acn3.566.
|
Young, PNE;
Estarellas, M;
Coomans, E;
Srikrishna, M;
Beaumont, H;
Maass, A;
Venkataraman, AV;
... Schöll, M; + view all
(2020)
Imaging biomarkers in neurodegeneration: current and future practices.
Alzheimer's Research & Therapy
, 12
, Article 49. 10.1186/s13195-020-00612-7.
|
Zetterberg, H;
Alawode, D;
Keshavan, A;
o'connor, A;
Weston, P;
Paterson, R;
Heslegrave, A;
... Schott, J; + view all
(2020)
Blood Tests for Alzheimer Disease.
Practical Neurology
|
Ziff, Oliver J;
Ashton, Nicholas J;
Mehta, Puja R;
Brown, Rachel;
Athauda, Dilan;
Heaney, Judith;
Heslegrave, Amanda J;
... Paterson, Ross W; + view all
(2022)
Amyloid processing in COVID-19-associated neurological syndromes.
Journal of Neurochemistry
, 161
(2)
pp. 146-157.
10.1111/jnc.15585.
|
Thesis
Paterson, RW;
(2017)
Cerebrospinal fluid biomarkers in Alzheimer’s Disease: from bedside to bench and back.
Doctoral thesis , UCL (University College London).
|